Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0076
-0.0004 (-5.00%)
Aug 19, 2026, 3:54 PM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $1.06 million as of August 19, 2026. Its market cap has decreased by -4.94% in one year.
Market Cap
1.06M
Enterprise Value
60.41M
Revenue
18.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 1.06M, a decrease of -99.51%. That is a compound annual growth rate of -46.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.06M | -11.90% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sirona Biochem | 1.35M |
| Neon Bloom | 1.27M |
| Abpro Holdings | 1.23M |
| CERo Therapeutics Holdings | 1.05M |
| Avenue Therapeutics | 848.78K |
| Emmaus Life Sciences | 807.17K |
| ZyVersa Therapeutics | 801.50K |
| Agentix | 801.34K |